Pulmonx Corp. (LUNG) PT Raised to $12 at Citi, Downgraded From Buy-High Risk to Buy
Tweet Send to a Friend
Citi analyst Joanne Wuensch raised the price target on Pulmonx Corp. (NASDAQ: LUNG) to $12.00 (from $10.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
